DAB.bio

DAB.bio is a Delft-based industrial biotechnology company that licenses fermentation process technology rather than developing therapeutic drug candidates. Its core FAST platform, short for Fermentation Accelerated by Separation Technology, integrates continuous fermentation with in situ product removal and biomass retention to improve productivity and lower manufacturing cost. The company positions the platform for large-scale production of chemicals, foods, fuels, proteins, and other bio-based products from renewable feedstocks. DAB.bio also provides process development, pilot-scale support, and deployment assistance for customers implementing the technology. The business appears to be commercially active, with product launches, partner activity, and recent financing to support full-scale deployment.